Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
303M
-
Number of holders
-
242
-
Total 13F shares, excl. options
-
205M
-
Shares change
-
+16.1M
-
Total reported value, excl. options
-
$4.2B
-
Value change
-
+$312M
-
Put/Call ratio
-
0.41
-
Number of buys
-
112
-
Number of sells
-
-112
-
Price
-
$20.46
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q4 2021
301 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q4 2021.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 242 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 205M shares
of 303M outstanding shares and own 67.8% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (26.4M shares), VANGUARD GROUP INC (19.9M shares), BlackRock Inc. (16.6M shares), Jackson Square Partners, LLC (14.5M shares), Capital International Investors (12.1M shares), Sumitomo Mitsui Trust Holdings, Inc. (11.9M shares), Nikko Asset Management Americas, Inc. (11.9M shares), SB Management Ltd (8.16M shares), Casdin Capital, LLC (7.99M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (5.83M shares).
This table shows the top 242 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.